Congenital platelet disorders.

Abstract:

:Congenital platelet disorders include thrombocytopathies and thrombocytopenias, which often occur in association. Thrombocytopathies constitute a model for exploring platelet physiology at the molecular level: adhesion, activation, release phenomena, aggregation. Further advances in understanding thrombocytopenias now require studies of medullary physiology. A better knowledge of these disorders is necessary to improve their management.

journal_name

Blood Rev

journal_title

Blood reviews

authors

Bellucci S,Caen JP

doi

10.1016/0268-960x(88)90004-5

subject

Has Abstract

pub_date

1988-03-01 00:00:00

pages

16-26

issue

1

eissn

0268-960X

issn

1532-1681

pii

0268-960X(88)90004-5

journal_volume

2

pub_type

杂志文章,评审
  • Modifying perioperative blood loss.

    abstract::Fears about the risks of disease transmission through the transfusion of homologous blood, as well as problems with blood supply and cost have increased the interest in reducing perioperative bleeding. This article discusses the causes of non-surgical perioperative bleeding and attempts to reduce perioperative bleedin...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(91)90034-a

    authors: Hunt BJ

    更新日期:1991-09-01 00:00:00

  • Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.

    abstract::Parenteral arsenic trioxide (ATO) has been firmly established as a standard therapy for acute promyelocytic leukemia (APL). Despite widespread use of oral arsenicals in medicine historically, they had disappeared from modern pharmacopeia until oral ATO was redeveloped in Hong Kong in 2000. Since then, over 200 patient...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2015.11.004

    authors: Torka P,Al Ustwani O,Wetzler M,Wang ES,Griffiths EA

    更新日期:2016-05-01 00:00:00

  • Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia.

    abstract::Fanconi anemia (FA) is a rare autosomal and X-linked genetic disease characterized by congenital abnormalities, progressive bone marrow failure (BMF), and increased cancer risk during early adulthood. The median lifespan for FA patients is approximately 33years. The proteins encoded by the FA genes function together i...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2016.10.002

    authors: Mamrak NE,Shimamura A,Howlett NG

    更新日期:2017-05-01 00:00:00

  • MDS: Refining existing therapy through improved biologic insights.

    abstract::Advances in therapy can essentially be measured using two parameters; introduction of a new agent which benefits an increased number of patients over prevailing treatments or more selective use of an existing drug by matching it to the biologic characteristics associated with response. In reviewing the therapeutic lan...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2011.11.001

    authors: Schecter J,Galili N,Raza A

    更新日期:2012-03-01 00:00:00

  • Treatment of early stage Hodgkin's disease.

    abstract::Current trends in the treatment of patients with Stages I and II Hodgkin's disease are discussed in this review. Recommendations for staging procedures and the updated staging classification are described. Long-term results with extended field radiation therapy overall and in subgroups of patients are detailed. As fol...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(93)90022-v

    authors: Straus DJ

    更新日期:1993-03-01 00:00:00

  • CML vaccines as a paradigm of the specific immunotherapy of cancer.

    abstract::T cells are implicated in the effective control of chronic myeloid leukemia (CML). Recently, several clinical observations supported by laboratory data, indicate the presence of CML-specific T cells. Many proteins potentially act as leukemia-specific antigens for MHC-restricted cytotoxicity in CML. These include the b...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1054/blre.2000.0127

    authors: Pinilla-Ibarz J,Cathcart K,Scheinberg DA

    更新日期:2000-06-01 00:00:00

  • Autologous and allogeneic stem cell transplantation for myelodysplastic syndrome.

    abstract::Allogeneic stem cell transplantation (alloSCT) is the treatment of choice in the majority of young patients with advanced stages MDS if they have a suitable donor. Since outcome of transplantation is superior for patients with a low blast percentage, this supports the use of chemotherapy prior to transplantation in pa...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2006.03.002

    authors: de Witte T,Oosterveld M,Muus P

    更新日期:2007-01-01 00:00:00

  • A logical approach to the investigation of red cell enzymopathies.

    abstract::This relatively rare group of disorders may cause quite marked morbidity and occasionally be life-threatening. As their inheritance is largely known accurate information in one family member has obvious benefits to other family members as well as the patient. The identification of the defect is dependent on an accurat...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(90)90042-q

    authors: Lestas AN,Bellingham AJ

    更新日期:1990-09-01 00:00:00

  • What can we learn from ineffective erythropoiesis in thalassemia?

    abstract::Erythropoiesis is a dynamic process regulated at multiple levels to balance proliferation, differentiation and survival of erythroid progenitors. Ineffective erythropoiesis is a key feature of various diseases, including β-thalassemia. The pathogenic mechanisms leading to ineffective erythropoiesis are complex and sti...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2017.10.001

    authors: Oikonomidou PR,Rivella S

    更新日期:2018-03-01 00:00:00

  • Management of refractory idiopathic thrombocytopenia.

    abstract::In refractory thrombocytopenia one should first evaluate whether the therapeutic approach has more risks to the patient than no treatment at all. The patient may remain relatively asymptomatic and the only incommoding circumstances be cosmetic. Coincidental medical problems such as hypertension and peptic ulceration a...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90020-3

    authors: Firkin BG,Hunt HA,Jane SM

    更新日期:1988-09-01 00:00:00

  • DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.

    abstract::Reactivation of fetal hemoglobin (HbF) expression is an important therapeutic option in patients with hemoglobin disorders. In sickle cell disease (SCD), an increase in HbF would interfere with the polymerization of sickle hemoglobin while in beta-thalassemia, an increase in gamma-globin chain synthesis would decrease...

    journal_title:Blood reviews

    pub_type: 杂志文章

    doi:10.1016/j.blre.2006.01.002

    authors: Fathallah H,Atweh GF

    更新日期:2006-07-01 00:00:00

  • Increased bone resorption in hemophilia.

    abstract::In patients with hemophilia, osteoporosis is frequently observed for which the etiology remains unclear. The aim of this paper is to review the available experimental evidence indicating the presence of this disorder in patients with hemophilia, explore the potential mechanisms which may lead to reduced bone mineral d...

    journal_title:Blood reviews

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.blre.2018.05.002

    authors: Rodriguez-Merchan EC,Valentino LA

    更新日期:2019-01-01 00:00:00

  • Thrombophilia and fetal loss.

    abstract::Recurrent fetal loss and other placental vascular pathologies of pregnancy have long been associated with antiphospholipid syndrome-an acquired autoimmune thrombophilic state. The number of known heritable thrombophilic disorders has grown rapidly in recent years with the identification of activated protein C resistan...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(97)90013-8

    authors: Brenner B,Blumenfeld Z

    更新日期:1997-06-01 00:00:00

  • Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues.

    abstract::Long-term survival rates in childhood acute lymphoblastic leukemia (ALL) are currently above 85% due to huge improvements in treatment. However, 15-20% of children still experience relapses. Relapses can either occur in the bone marrow or at extramedullary sites, such as gonads or the central nervous system (CNS), for...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2019.04.003

    authors: Gaudichon J,Jakobczyk H,Debaize L,Cousin E,Galibert MD,Troadec MB,Gandemer V

    更新日期:2019-07-01 00:00:00

  • Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction.

    abstract::The innate immune system orchestrated by leukocytes primarily neutrophils, serves to remove dead and dying host cells and to provide protection against invasion by pathogens. Failure of this system results in the onset of sepsis leading to grave consequences for the host. Together with mechanical methods to physically...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2012.09.001

    authors: Gardiner EE,Andrews RK

    更新日期:2012-11-01 00:00:00

  • Transfusion strategies for traumatic coagulopathy.

    abstract::Uncontrolled bleeding is the most common preventable cause of death for patients with severe injury. Coagulopathy inevitably accompanies severe bleeding, exacerbated by the ongoing blood loss and the treatments administered. There is debate about the underlying pathophysiological mechanisms of early traumatic coagulop...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2012.06.004

    authors: Curry NS,Davenport RA,Hunt BJ,Stanworth SJ

    更新日期:2012-09-01 00:00:00

  • Infectious agents and environmental factors in lymphoid malignancies.

    abstract::A strong association was found to exist between patterns of lymphoid malignancies and socioeconomic status. B-cell lymphomas and T-acute lymphoblastic leukemia are much more prevalent in developing countries where the chances of acquiring infections especially at a younger age are high. B-cell precursor acute lymphati...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(96)90037-5

    authors: Toren A,Ben-Bassat I,Rechavi G

    更新日期:1996-06-01 00:00:00

  • MicroRNAs in hematological malignancies.

    abstract::MicroRNAs (miRNAs) have become one of the hottest topics in biology over recent years, but remarkably have only been formally recognized for just over 10 years. These endogenously produced short (19-24 nt) non-coding RNAs have introduced an entirely new paradigm in our understanding of gene control and it is now evide...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2013.04.002

    authors: Lawrie CH

    更新日期:2013-05-01 00:00:00

  • Resuscitation and transfusion principles for traumatic hemorrhagic shock.

    abstract::The transfusion approach to massive hemorrhage has continually evolved since it began in the early 1900s. It started with fresh whole blood and currently consists of virtually exclusive use of component and crystalloid therapy. Recent US military experience has reinvigorated the debate on what the most optimal transfu...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2009.07.003

    authors: Spinella PC,Holcomb JB

    更新日期:2009-11-01 00:00:00

  • Treatment of newly diagnosed advanced stage Hodgkin lymphoma.

    abstract::ABVD continues to be the standard of care for patients with advanced stage Hodgkin Lymphoma (HL) although escalated BEACOPP has improved survival in one randomized controlled trial (RCT). More intensive regimens have higher rates of acute and late toxicities and this poses significant issues for patients. Consolidatio...

    journal_title:Blood reviews

    pub_type: 杂志文章,随机对照试验,评审

    doi:10.1016/j.blre.2012.04.001

    authors: Uhm J,Kuruvilla J

    更新日期:2012-07-01 00:00:00

  • FDG-PET imaging in hematological malignancies.

    abstract::The majority of aggressive lymphomas is characterized by an up regulated glycolytic activity, which enables the visualization by F-18 FDG-PET/CT. One-stop hybrid FDG-PET/CT combines the functional and morphologic information, outperforming both, CT and FDG-PET as separate imaging modalities. This has resulted in sever...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2016.02.003

    authors: Valls L,Badve C,Avril S,Herrmann K,Faulhaber P,O'Donnell J,Avril N

    更新日期:2016-07-01 00:00:00

  • Enzyme therapy for Gaucher disease: the first 5 years.

    abstract::Gaucher disease was first described by Philippe Gaucher in his 1882 medical thesis. Gaucher's original concept was of an unusual epithelioma of the spleen. By the early 1900s, Mandelbaum recognized the systemic nature of the disease. Several children with Gaucher disease were described at the turn of the century, but ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(98)90023-6

    authors: Grabowski GA,Leslie N,Wenstrup R

    更新日期:1998-06-01 00:00:00

  • Controversies surrounding iron chelation therapy for MDS.

    abstract::The myelodysplastic syndromes (MDS) are characterized by cytopenias and acute myeloid leukemia risk. Most MDS patients eventually require transfusion of red blood cells for anemia, placing them at risk of iron overload (IOL). In beta-thalassemia major, transfusional IOL leads to organ dysfunction and death, however, w...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2010.09.003

    authors: Leitch HA

    更新日期:2011-01-01 00:00:00

  • Veno-occlusive disease: cytokines, genetics, and haemostasis.

    abstract::Hepatic veno-occlusive disease (VOD) is a major cause of morbidity and mortality following high dose cytotoxic therapy for stem cell transplantation (SCT). Pre-existing liver damage, SCT-related therapy, and genetic polymorphisms all appear to increase the risk of developing VOD. Studies of biological markers during S...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(03)00002-x

    authors: Coppell JA,Brown SA,Perry DJ

    更新日期:2003-06-01 00:00:00

  • Hemophagocytic syndromes.

    abstract::Hemophagocytic syndromes (hemophagocytic lymphohistiocytosis, HLH) represent a severe hyperinflammatory condition with the cardinal symptoms prolonged fever, cytopenias, hepatosplenomegaly, and hemophagocytosis by activated, morphologically benign macrophages. Biochemical markers include elevated ferritin and triglyce...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2007.05.001

    authors: Janka GE

    更新日期:2007-09-01 00:00:00

  • Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst.

    abstract::Myeloid neoplasms like acute myeloid leukemia (AML) originate from genomic disruption, usually in a multi-step fashion. Hematopoietic stem/progenitor cell acquisition of abnormalities in vital cellular processes, when coupled with intrinsic factors such as germline predisposition or extrinsic factors such as the marro...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100760

    authors: Shallis RM,Weiss JJ,Deziel NC,Gore SD

    更新日期:2020-09-22 00:00:00

  • Infection control in patients with myelodysplastic syndromes who are candidates for active treatment: Expert panel consensus-based recommendations.

    abstract::The improvement in supportive care and the introduction of new therapeutic agents, including lenalidomide and hypomethylating agents, in myelodysplastic syndromes have improved patients' outcomes; however, at the same time, the frequency and epidemiology of infections have changed. Therefore, the great strides in the ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2018.10.002

    authors: Girmenia C,Candoni A,Delia M,Latagliata R,Molteni A,Oliva EN,Palumbo GA,Poloni A,Salutari P,Santini V,Voso MT,Musto P

    更新日期:2019-03-01 00:00:00

  • Optimizing platelet transfusion therapy.

    abstract::Platelet transfusions are widely used. Prophylactic transfusions are employed in severely thrombocytopenic patients without evidence of bleeding, but no randomized trial data prove the safety or efficacy of this approach. Randomized trials have demonstrated the equivalence of transfusion triggers of 10,000 and 20,000/...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/S0268-960X(03)00057-2

    authors: Heal JM,Blumberg N

    更新日期:2004-09-01 00:00:00

  • Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantation.

    abstract::The rate of relapse after allogeneic bone marrow transplantation (BMT) varies between 15 and 60%. New therapeutic strategies are required urgently as no significant results have been obtained with standard chemotherapy. The best results of second allogeneic BMT have been obtained when the interval between the first an...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(94)90111-2

    authors: Boiron JM,Cony-Makhoul P,Mahon FX,Pigneux A,Puntous M,Reiffers J

    更新日期:1994-12-01 00:00:00

  • Platelet-neutrophil interactions: their significance.

    abstract::In the vicinity of an acute inflammatory response both cellular and non-cellular elements may interact to modify the overall response. Evidence suggests that leukocytes may play an active role in the modulation of platelet function and vice-versa. This interaction may be abnormal in certain pathological states. Neutro...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(92)90010-n

    authors: Faint RW

    更新日期:1992-06-01 00:00:00